标题
Assessing the Immunogenicity of Biopharmaceuticals
作者
关键词
European Medicine Agency, Reference Product, Risk Management Plan, Immunogenicity Assessment, Immunogenicity Rate
出版物
BIODRUGS
Volume 30, Issue 3, Pages 195-206
出版商
Springer Nature
发表日期
2016-04-20
DOI
10.1007/s40259-016-0174-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis
- (2015) Noortje van Herwaarden et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity assessment of biotherapeutic products: An overview of assays and their utility
- (2015) Meenu Wadhwa et al. BIOLOGICALS
- Therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein products
- (2015) Liusong Yin et al. CELLULAR IMMUNOLOGY
- Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
- (2015) B. Rup et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients
- (2015) Karien Bloem et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Comparative immunogenicity assessment: a critical consideration for biosimilar development
- (2015) Patrick M Liu et al. Bioanalysis
- Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
- (2014) G. Shankar et al. AAPS Journal
- The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper
- (2014) Gionata Fiorino et al. AUTOIMMUNITY REVIEWS
- Regulatory and clinical considerations for biosimilar oncology drugs
- (2014) Charles L Bennett et al. LANCET ONCOLOGY
- Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study
- (2014) Nobuyuki Miyasaka et al. Modern Rheumatology
- Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
- (2014) Aldona Mularczyk et al. Przeglad Gastroenterologiczny
- Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
- (2014) Morton Scheinberg et al. ARTHRITIS RESEARCH & THERAPY
- Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
- (2013) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- Peri-Infusional Adverse Reactions to Rituximab in Patients with Non-Hodgkin's Lymphoma
- (2013) Teresa Arredondo-Garza et al. ARCHIVES OF MEDICAL RESEARCH
- Joint position statement by "Sociedad Española de Patología Digestiva" (Spanish Society of Gastroenterology) and "Sociedad Española de Farmacología" (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel disease
- (2013) Federico Argüelles-Arias et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Assessing immunogenicity of biosimilar therapeutic monoclonal antibodies: regulatory and bioanalytical considerations
- (2013) Paul Chamberlain Bioanalysis
- Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
- (2012) Fabien B Vincent et al. ANNALS OF THE RHEUMATIC DISEASES
- Biosimilars and biobetters as tools for understanding and mitigating the immunogenicity of biotherapeutics
- (2012) Maria D.F.S. Barbosa et al. DRUG DISCOVERY TODAY
- Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine
- (2012) Klaus Bendtzen Immunotherapy
- Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum
- (2012) Shui-Long Wang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Interchangeability, immunogenicity and biosimilars
- (2012) Hans C Ebbers et al. NATURE BIOTECHNOLOGY
- Challenges of developing and validating immunogenicity assays to support comparability studies for biosimilar drug development
- (2012) Xiao-Yan Cai et al. Bioanalysis
- Taking immunogenicity assessment of therapeutic proteins to the next level
- (2011) I.C. Büttel et al. BIOLOGICALS
- Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation
- (2011) G. Barosi et al. HAEMATOLOGICA
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential effect of drug interference in immunogenicity assays
- (2011) Margreet H. Hart et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis
- (2011) D. Pascual-Salcedo et al. RHEUMATOLOGY
- Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study
- (2011) Geertje M Bartelds et al. ARTHRITIS RESEARCH & THERAPY
- Dealing with immunogenicity of biologicals: assessment and clinical relevance
- (2010) Gerrit J Wolbink et al. CURRENT OPINION IN RHEUMATOLOGY
- Immunogenicity of therapeutics: a matter of efficacy and safety
- (2010) Andreas Nechansky et al. Expert Opinion on Drug Discovery
- A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients
- (2010) Pauline A. van Schouwenburg et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Biopharmaceutical benchmarks 2010
- (2010) Gary Walsh NATURE BIOTECHNOLOGY
- Immunogenicity of rituximab in patients with severe pemphigus
- (2009) Enno Schmidt et al. CLINICAL IMMUNOLOGY
- How to systematically evaluate immunogenicity of therapeutic proteins – regulatory considerations
- (2009) Eva-Maria Jahn et al. New Biotechnology
- Immunogenicity of anti-tumor necrosis factor antibodies—toward improved methods of anti-antibody measurement
- (2008) Lucien Aarden et al. CURRENT OPINION IN IMMUNOLOGY
- Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore
- (2008) Denise Sickert et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
- (2008) Eugen Koren et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
- (2008) Gopi Shankar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More